Where Vision Meets the Industry
At the 11th Pharmacovigilance & RWE Conference 2026, Aliteware shared perspectives on integrated and automated safety surveillance, including medical-information contact-centre automation.
Follow our participation in the life-sciences community and our work on AI-enabled pharmacovigilance.
Contact us →At the 11th Pharmacovigilance & RWE Conference 2026, Aliteware shared perspectives on integrated and automated safety surveillance, including medical-information contact-centre automation.
Participation in discussions on medical-device safety and regulatory compliance, reflecting the company’s focus on innovation across life sciences.
Engagement with industry peers on AI challenges, evaluation metrics and strategies for regulatory compliance.
A session on key considerations for qualifying AI solutions in pharmacovigilance environments.
Discussion of practical challenges in literature monitoring, automation limits and workable approaches for global and local sources.
Participation as a Gold Sponsor in Amsterdam, sharing perspectives on AI-driven automation and pharmacovigilance.